Related Experiment Video

Updated: Aug 23, 2026

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts
11:19

Merging Absolute and Relative Quantitative PCR Data to Quantify STAT3 Splice Variant Transcripts

Published on: October 9, 2016

Signal transducer and activator of transcription 5 (STAT5)

Miranda Buitenhuis1, Paul J Coffer, Leo Koenderman

  • 1Department of Pulmonary Diseases, G03.550, University Medical Center, Heidelberglaan 100, 3584 CX Utrecht, The Netherlands. m.buitenhuis@hli.azu.nl

The International Journal of Biochemistry & Cell Biology
|August 18, 2004
PubMed

Insights

Signal transducer and activator of transcription 5 (STAT5) is crucial for cell functions and is implicated in various cancers. Researchers are developing kinase inhibitors to target STAT5 activity for therapeutic benefits.

Area of Science:

  • Molecular Biology
  • Cellular Biology
  • Oncology

Background:

  • Signal transducer and activator of transcription 5 (STAT5) is a key transcription factor activated by cytokines and growth factors.
  • STAT5 regulates critical cellular processes such as proliferation, differentiation, and apoptosis.
  • Dysregulated STAT5 signaling is linked to the development and progression of various cancers, including myeloid leukemias and solid tumors.

Purpose of the Study:

  • To investigate the role of STAT5 in cellular processes.
  • To explore the aberrant regulation of STAT5 in malignancies.
  • To highlight the therapeutic potential of targeting STAT5 in cancer treatment.

Main Methods:

  • Review of existing literature on STAT5 signaling pathways.
  • Analysis of studies linking STAT5 dysregulation to cancer.
  • Examination of preclinical and clinical data on kinase inhibitors targeting STAT5.

Main Results:

  • STAT5 activation by diverse stimuli leads to the transcription of specific target genes.
  • Aberrant STAT5 signaling is a common feature in both solid tumors and hematological malignancies.
  • Kinase inhibitors targeting STAT5 are under active development for clinical application.

Conclusions:

  • STAT5 is a critical mediator of cellular functions with significant implications in cancer.
  • Targeting STAT5 with kinase inhibitors represents a promising therapeutic strategy for various cancers.
  • Further research into STAT5 regulation and inhibition is warranted for effective cancer therapy.

More Related Videos

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells07:12

Time-resolved Förster Resonance Energy Transfer Assays for Measurement of Endogenous Phosphorylated STAT Proteins in Human Cells

Published on: September 9, 2021

Chromatin Immunoprecipitation (ChIP) to Assay Dynamic Histone Modification in Activated Gene Expression in Human Cells13:20

Chromatin Immunoprecipitation (ChIP) to Assay Dynamic Histone Modification in Activated Gene Expression in Human Cells

Published on: July 29, 2010

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Eukaryotic Transcription Activators02:42

Eukaryotic Transcription Activators

Transcription activators are proteins that promote the transcription of genes from DNA to RNA. In most cases, these proteins contain two separate domains ‒ a domain that binds to DNA and a domain for activating transcription; however, in some cases, a single domain is responsible for both binding and activation of transcription, as seen in the glucocorticoid receptor and MyoD.
The binding domains are capable of recognizing and interacting with regulatory sequences on the DNA. These domains are...